What do the studies say about CBD and other cannabinoids and their impact on Eczema?
Let’s jump into it…
The study started out by stating what Atopic Dermatitis is, which they described as a chronic inflammatory skin condition that can damage the skin, negatively impact your immune system, and even throw off the healthy balance of microbiota that is found living in the skin (which can predispose you to more complications) (Baswan, et al., 2020).
CBD and other cannabinoids that can be found in cannabis (Hemp) have shown to be a promising future for treatment due to its anti-inflammatory, skin protectant, anti-microbial properties (Baswan, et al., 2020). CBD was able to control the inflammation response, modulate the immune response, and keep a healthy, homeostasis within the skin, which the health experts said was beneficial when discussing eczema (Baswan, et al., 2020).
The study then concluded that it may not be the actual CBD compounds that exhibit the antibacterial properties, in fact they say this is due to the terpene profile that is found in hemp and included the terpenes “…myrcene, α-pinene, β-caryophyllene…” (Baswan, et al., 2020).
We know that terpene profiles are important because different terpenes give you different effects and a great example is a sativa vs an indica. Well, now we know that the terpenes have antibacterial properties towards the harmful bacteria that can be disrupting our skin's balance (Baswan, et al., 2020).
These phytocannabinoids (plant compounds) are once again showing its impact on our wellbeing.
I know I have said this before, but it's almost like our creator designed this plant for us in almost every way imaginable, weird. 😉
*This information is for educational purposes only and simply sharing of the information pertained to this particular study. No medical advice or claims are being made.
Baswan, S. M., Klosner, A. E., Glynn, K., Rajgopal, A., Malik, K., Yim, S., & Stern, N. (2020). Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders. Clinical, cosmetic and investigational dermatology, 13, 927–942. https://doi.org/10.2147/CCID.S286411